临床病理学特征和CD30表达的生存结果在外节自然杀手/T细胞淋巴瘤中

Ziyuan Shen1, Yubo Wang2, Ruiyang Xie3

  • 1Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China; Departments of.

概括

阳性CD30表达是外节自然杀手/T细胞淋巴瘤 (ENKTL) 的有利预后指标. 这一发现有助于在临床子组内重新确定患者生存率,改善ENKTL预后预测.